Joylette L. Portlock, Ph.D. - Publications

Affiliations: 
2006 Stanford University, Palo Alto, CA 
Area:
Genetics, Medicine and Surgery

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Portlock JL, Keravala A, Bertoni C, Lee S, Rando TA, Calos MP. Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. Human Gene Therapy. 17: 871-6. PMID 16942446 DOI: 10.1089/Hum.2006.17.871  1
2006 Keravala A, Portlock JL, Nash JA, Vitrant DG, Robbins PD, Calos MP. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints. The Journal of Gene Medicine. 8: 1008-17. PMID 16779871 DOI: 10.1002/Jgm.928  0.52
2006 Chalberg TW, Portlock JL, Olivares EC, Thyagarajan B, Kirby PJ, Hillman RT, Hoelters J, Calos MP. Integration specificity of phage phiC31 integrase in the human genome. Journal of Molecular Biology. 357: 28-48. PMID 16414067 DOI: 10.1016/J.Jmb.2005.11.098  0.52
2005 Portlock JL, Chalberg TW, Olivares EC, Thyagarajan B, Kirby PJ, Calos MP. 194. Characteristics of Site-Specific Integration as Mediated by PhiC31 Integrase in the Human Genome Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.197  1
2004 Chalberg TW, Ginsburg DS, Kirby PJ, Olivares EC, Portlock JL, Thyagarajan B, Calos MP. 814. Integration Sites Used by the PhiC31 Site-Specific Integrase in the Human Genome Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.712  1
2004 Keravala A, Nash J, Portlock JL, Robbins PD, Calos MP. 809. PhiC31 Integrase Mediates Site-Specific Genomic Integration in Rabbit Cells and Rabbit Knee Joints Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.707  1
2003 Portlock JL, Calos MP. Site-specific genomic strategies for gene therapy. Current Opinion in Molecular Therapeutics. 5: 376-82. PMID 14513680  1
Show low-probability matches.